Given the high prevalence of HP infection in many populations, screening and treatment for HP could potentially reduce ASCVD risk which might justify the reduced effect of thyroid hormones in arterial smooth muscle relaxation leading to increased systemic vascular resistance and reduced endothelium-dependent vasodilatation and nitricoxide availability. The gene discussed is TG; the disease is atherosclerosis.